Pacific Biosciences Of Stock Market Value
| PACB Stock | USD 1.60 0.04 2.56% |
| Symbol | Pacific |
Pacific Biosciences Price To Book Ratio
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.46) | Revenue Per Share | Quarterly Revenue Growth (0.28) | Return On Assets | Return On Equity |
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pacific Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pacific Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pacific Biosciences.
| 12/31/2024 |
| 01/30/2025 |
If you would invest 0.00 in Pacific Biosciences on December 31, 2024 and sell it all today you would earn a total of 0.00 from holding Pacific Biosciences of or generate 0.0% return on investment in Pacific Biosciences over 30 days. Pacific Biosciences is related to or competes with Twist Bioscience, Intellia Therapeutics, Crispr Therapeutics, and Editas Medicine. Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically co... More
Pacific Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pacific Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pacific Biosciences of upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 26.42 | |||
| Value At Risk | (9.69) | |||
| Potential Upside | 10.56 |
Pacific Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pacific Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pacific Biosciences' standard deviation. In reality, there are many statistical measures that can use Pacific Biosciences historical prices to predict the future Pacific Biosciences' volatility.| Risk Adjusted Performance | 0.0083 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | 0.2339 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pacific Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pacific Biosciences Backtested Returns
Pacific Biosciences maintains Sharpe Ratio (i.e., Efficiency) of -0.095, which implies the firm had a -0.095 % return per unit of risk over the last 3 months. Pacific Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pacific Biosciences' Risk Adjusted Performance of 0.0083, coefficient of variation of (288,585), and Variance of 34.92 to confirm the risk estimate we provide. The company holds a Beta of -0.0515, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Pacific Biosciences are expected to decrease at a much lower rate. During the bear market, Pacific Biosciences is likely to outperform the market. At this point, Pacific Biosciences has a negative expected return of -0.54%. Please make sure to check Pacific Biosciences' standard deviation, maximum drawdown, kurtosis, as well as the relationship between the total risk alpha and potential upside , to decide if Pacific Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.43 |
Average predictability
Pacific Biosciences of has average predictability. Overlapping area represents the amount of predictability between Pacific Biosciences time series from 31st of December 2024 to 15th of January 2025 and 15th of January 2025 to 30th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pacific Biosciences price movement. The serial correlation of 0.43 indicates that just about 43.0% of current Pacific Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.43 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Pacific Biosciences lagged returns against current returns
Autocorrelation, which is Pacific Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pacific Biosciences' stock expected returns. We can calculate the autocorrelation of Pacific Biosciences returns to help us make a trade decision. For example, suppose you find that Pacific Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pacific Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pacific Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pacific Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pacific Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Pacific Biosciences Lagged Returns
When evaluating Pacific Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pacific Biosciences stock have on its future price. Pacific Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pacific Biosciences autocorrelation shows the relationship between Pacific Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Pacific Biosciences of.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:Check out Pacific Biosciences Correlation, Pacific Biosciences Volatility and Pacific Biosciences Alpha and Beta module to complement your research on Pacific Biosciences. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Pacific Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.